| HOME >> MEDICINE >> TECHNOLOGY |
5,860,4412,293,410Deferred rent
90,902101,133Deferred grant income
82,650107,481Deferred income taxes
194,244188,177Total liabilities
6,228,2372,690,201Total stockholders' equity
24,218,19016,752,590Total liabilities and stockholders' equity
$
30,446,427$
9,442,791 The Female Health CompanyUnaudited Condensed Consolidated Income Statements Three Months Ended
September 30, 20122011Net revenues
$ 9,911,701$ 7,109,050Cost of sales
4,161,5372,881,697Gross profit
5,750,1644,227,353Operating expenses
2,564,7911,917,784Operating income
3,185,3732,309,569Interest and other (expense) income
(551)814Foreign currency transaction (loss) gain
(78,975)12,993Income before income taxes
3,105,8472,323,376Income tax benefit
(5,079,358)(2,191,342)Net income
$ 8,185,205$ 4,514,718Net income per basic common share outstanding
$ 0.29$ 0.17Basic weighted average common shares outstanding
28,180,00127,301,422Net income per diluted common share outstanding
$ 0.29$ 0.16Diluted weighted average common shares outstanding
28,678,08128,891,118 The Female Health CompanyUnaudited Condensed Consolidated Income Statements Year EndedSeptember 30,20122011Net revenues
$ 35,033,897$ 18,565,102Cost of sales
14,412,8848,699,912Gross profit
20,621,0139,865,190Operating expenses
9,681,0836,569,848Operating income
10,939,9303,295,342Interest and other income (expense)
362(2,109)Foreign currency transaction loss
(148,269)(61,258)Income before income taxes
10,792,0233,231,975Income tax benefit
(4,507,298)(2,167,076)Net income
$ 15,299,321$ 5,399,051Net income per basic common share outstanding
$ 0.55$ 0.20Basic weighted average common shares outstanding
27,693,72127,287,342Net income
'/>"/>
| SOURCE The Female Health Company Copyright©2012 PR Newswire. All rights reserved |